ArticleAsian journal of pharmaceutical sciences2025

Enhancing chemoimmunotherapy for colorectal cancer with paclitaxel and alantolactone via CD44-Targeted nanoparticles: A STAT3 signaling pathway modulation approach.

Fugen Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.